Home » Topics » Conferences

Conferences
RSS

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

Novartis' NK1 antagonist in clinical studies for pain

Nov. 20, 1997

GL-701 shows significant steroid-sparing effects in women with active SLE

Nov. 20, 1997

New ACAT inhibitor from Pierre Fabre

Nov. 20, 1997

Enbrel phase III and long-term safety data presented at rheumatology meeting

Nov. 20, 1997

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Nov. 20, 1997

Effects of rPAF-AH in opossums with severe pancreatitis

Nov. 20, 1997

Thalidomide proves effective in HIV-associated proctitis

Nov. 20, 1997

L-Arginine safe and effective in spastic esophageal motor disorders

Nov. 19, 1997

New laxative proves safe and effective for short-term treatment of constipation

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.